These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19907182)

  • 1. Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients.
    Isobe C; Abe T; Terayama Y
    Dement Geriatr Cogn Disord; 2009; 28(5):449-54. PubMed ID: 19907182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease.
    Isobe C; Murata T; Sato C; Terayama Y
    J Clin Neurosci; 2007 Apr; 14(4):340-3. PubMed ID: 16647853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.
    Isobe C; Abe T; Terayama Y
    Neurosci Lett; 2010 Jan; 469(1):159-63. PubMed ID: 19944739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis.
    Murata T; Ohtsuka C; Terayama Y
    J Neurol Sci; 2008 Apr; 267(1-2):66-9. PubMed ID: 17961597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.
    Isobe C; Abe T; Terayama Y
    J Neurol; 2010 Mar; 257(3):399-404. PubMed ID: 19784856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.
    Sohmiya M; Tanaka M; Tak NW; Yanagisawa M; Tanino Y; Suzuki Y; Okamoto K; Yamamoto Y
    J Neurol Sci; 2004 Aug; 223(2):161-6. PubMed ID: 15337618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease.
    Abe T; Tohgi H; Isobe C; Murata T; Sato C
    J Neurosci Res; 2002 Nov; 70(3):447-50. PubMed ID: 12391605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients.
    Sohmiya M; Tanaka M; Suzuki Y; Tanino Y; Okamoto K; Yamamoto Y
    J Neurol Sci; 2005 Jan; 228(1):49-53. PubMed ID: 15607210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coenzyme Q10 changes are associated with metabolic syndrome.
    Miles MV; Morrison JA; Horn PS; Tang PH; Pesce AJ
    Clin Chim Acta; 2004 Jun; 344(1-2):173-9. PubMed ID: 15149886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle coenzyme Q: a potential test for mitochondrial activity and redox status.
    Miles L; Miles MV; Tang PH; Horn PS; Wong BL; DeGrauw TJ; Morehart PJ; Bove KE
    Pediatr Neurol; 2005 May; 32(5):318-24. PubMed ID: 15866432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine may contribute to pathogenesis of RNA damage in brains with Alzheimer's disease.
    Isobe C; Abe T; Terayama Y
    Neurodegener Dis; 2009; 6(5-6):252-7. PubMed ID: 19940460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
    Isobe C; Murata T; Sato C; Terayama Y
    Life Sci; 2005 Aug; 77(15):1836-43. PubMed ID: 15935398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults.
    Miles MV; Horn PS; Tang PH; Morrison JA; Miles L; DeGrauw T; Pesce AJ
    Clin Chim Acta; 2004 Sep; 347(1-2):139-44. PubMed ID: 15313151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Diamandis EP; Scorilas A; Kishi T; Blennow K; Luo LY; Soosaipillai A; Rademaker AW; Sjogren M
    Clin Biochem; 2004 Mar; 37(3):230-7. PubMed ID: 14972646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquinol: a potential biomarker for tissue energy requirements and oxidative stress.
    Miles L; Miles MV; Tang PH; Horn PS; Quinlan JG; Wong B; Wenisch A; Bove KE
    Clin Chim Acta; 2005 Oct; 360(1-2):87-96. PubMed ID: 15935338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: preliminary studies.
    McIntyre JA; Chapman J; Shavit E; Hamilton RL; Dekosky ST
    Autoimmunity; 2007 Jul; 40(5):390-6. PubMed ID: 17612901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
    de la Monte SM; Volicer L; Hauser SL; Wands JR
    Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.
    Kanai M; Matsubara E; Isoe K; Urakami K; Nakashima K; Arai H; Sasaki H; Abe K; Iwatsubo T; Kosaka T; Watanabe M; Tomidokoro Y; Shizuka M; Mizushima K; Nakamura T; Igeta Y; Ikeda Y; Amari M; Kawarabayashi T; Ishiguro K; Harigaya Y; Wakabayashi K; Okamoto K; Hirai S; Shoji M
    Ann Neurol; 1998 Jul; 44(1):17-26. PubMed ID: 9667589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric reference intervals for muscle coenzyme Q(10).
    Pastore A; Di Giovamberardino G; Petrillo S; Boenzi S; Bertini E; Dionisi-Vici C; Piemonte F
    Biomarkers; 2012 Dec; 17(8):764-6. PubMed ID: 23020092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP; Jia JM; Zhou WD; Xu M; Chu CB; Yan X; Sun YX
    Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.